Results 151 to 160 of about 334,579 (212)

[Aplastic anemia and viral hepatitis (posthepatitic aplastic anemia)].

open access: yesTerapevticheskii arkhiv, 1999
To validate up-to-date policy of immunosuppressive therapy of patients with aplastic anemia (AA) which has developed either at acute or chronic phase of viral hepatitis.16 patients with AA detected within 6 months (9 patients) or 12-36 months (7 patients) after acute viral hepatitis received immunosuppressive therapy (antilymphocytic globulin ...
E A, Mikhaĭlova   +2 more
openaire   +1 more source

Perioperative Transfusion Trigger Score Versus Restrictive Transfusion in Older Non‐Cardiac Surgery Patients: A Multicenter Randomized Controlled Trial

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 9, Page 2564-2572, September 2026.
ABSTRACT Background Restrictive transfusion (Hb < 7 g/dL) is recommended for most perioperative patients, but the optimal threshold for those with cardiovascular disease or Hb 7–10 g/dL remains uncertain. The Perioperative Transfusion Trigger Score (POTTS), which integrates adrenaline requirement, FiO2, temperature, and angina history, may standardize ...
Shucong Liang   +9 more
wiley   +1 more source

Aplastic anemia - Treatment [PDF]

open access: yesDMW - Deutsche Medizinische Wochenschrift, 2003
R, Schroers, K, Hohloch, L, Trümper
openaire   +2 more sources

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

open access: yesBone Marrow Transplantation, 2019
P. Prata   +29 more
semanticscholar   +1 more source

Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells

open access: yes
British Journal of Haematology, Volume 209, Issue 3, Page 1399-1403, September 2026.
Malvina Bichon   +5 more
wiley   +1 more source

Use of eltrombopag in aplastic anemia in Europe

open access: yesAnnals of Hematology, 2019
M. Ecsedi   +28 more
semanticscholar   +1 more source

Aplastic anemia: Pathophysiology.

Seminars in Hematology, 2022
Bone marrow failure (BMF) syndromes are a heterogeneous group of benign hematological conditions characterized by uni- or multi-lineage marrow and/or peripheral blood cytopenia(s), and can be classified in constitutional or acquired syndromes based on ...
Valentina Giudice, C. Selleri
semanticscholar   +4 more sources

Current Concepts of the Pathogenesis of Aplastic Anemia

Current Pharmaceutical Design, 2019
Abnormal activation of the immune system plays an important role in the pathogenesis of aplastic anemia (AA). Various immune cells and cytokines constitute a complex immune network, leading to bone marrow failure. The known pathogenesis is an increase of
Zonghong Shao   +2 more
exaly   +2 more sources

Factitial Aplastic Anemia

The Journal of Nervous and Mental Disease, 1984
A 29-year-old married nurse with pancytopenia was discovered to be surreptitiously ingesting alkylating agents. Despite her life-threatening behavior, there was no evidence that she was psychotic, depressed, or cognitively impaired. Psychological testing was indicative of a sociopathic personality.
C V, Ford   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy